Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on News Channel Asia.
Press releases published on July 23, 2025
Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder
GlobeNewswire
·
July 23, 2025
Vancouver, Canada, July 23, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Tenvie Therapeutics Promotes Tony Estrada, PhD, to Chief Executive Officer
GlobeNewswire
·
July 23, 2025
SOUTH SAN FRANCISCO, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- Tenvie Therapeutics, a biotechnology company committed to engineering small molecules that transform the treatment of neurological diseases, today announced the appointment of Tony Estrada, Ph. …
Windward Bio Initiates Global Phase 2 Asthma Trial of WIN378, a Potential Best-in-Disease, Long-Acting, Anti-TSLP Monoclonal Antibody
GlobeNewswire
·
July 23, 2025
Phase 2 POLARIS trial will evaluate the dosing, safety, and efficacy of WIN378 in patients with asthma, with a first data readout expected in mid-2026 WIN378 has the potential to be the first-to-market long-acting, anti-TSLP antibody with twice-yearly …
Alkeus Pharmaceuticals Announces Gildeuretinol Data Presentations During the American Society of Retina Specialists (ASRS) 43rd Annual Meeting July 29-August 2
GlobeNewswire
·
July 23, 2025
CAMBRIDGE, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today announced that data from its clinical studies of …
IperionX – June 2025 Quarterly Report
GlobeNewswire
·
July 23, 2025
CHARLOTTE, N.C., July 23, 2025 (GLOBE NEWSWIRE) -- IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) is pleased to present its quarterly report for the period ending June 30, 2025. Key highlights during and subsequent to the end of the quarter include: …
Maxus Mining Expands Land Holdings at the Hurley Antimony Project in British Columbia, Canada
GlobeNewswire
·
July 23, 2025
VANCOUVER, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM | FRA: R7V), is pleased to announce that the Company has expanded its land holdings by approximately 2,431 hectares at the Hurley …
Aventis Energy Announces Results of High-Resolution TDEM Survey at the Corvo Uranium Project in Northern Saskatchewan
GlobeNewswire
·
July 23, 2025
VANCOUVER, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- Aventis Energy (“Aventis” or the “Company”) (CSE: AVE | FRA: C0O0 | OTC: VBAMF) is pleased to provide a summary of results from an airborne Time Domain Electromagnetic (“TDEM”) survey (the “ …
Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy
GlobeNewswire
·
July 23, 2025
SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announced that three …
NevGold Announces Up to 92% Antimony Recovery From Positive Metallurgical Testwork Program at Oxide Gold-Antimony Limo Butte Project in Nevada
GlobeNewswire
·
July 23, 2025
Vancouver, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce extremely positive antimony (“Antimony”, “Sb”) metallurgical testwork results at its …
Quanta Announces Leadership Team Appointment and Highlights Clinical Program Progress
GlobeNewswire
·
July 23, 2025
– 25-year industry veteran Vanessa L. Jacoby appointed CBO and CFO, bringing financial and strategic leadership – – Enrollment initiated in dose expansion cohorts in Phase 1 clinical trial of QTX3034, an oral G12D-preferring multi-KRAS inhibitor, in …
BitFuFuPool Surpasses 20 EH/s, Ranks Among Top Global Bitcoin Mining Pools
GlobeNewswire
·
July 23, 2025
SINGAPORE, July 23, 2025 (GLOBE NEWSWIRE) -- BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today announced that its private-label Bitcoin mining pool, BitFuFuPool, has surpassed 20 …
Revolution Medicines Announces FDA Breakthrough Therapy Designation for Elironrasib
GlobeNewswire
·
July 23, 2025
Breakthrough Therapy Designation granted to elironrasib for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer who have received prior chemotherapy and immunotherapy but have not been previously …
Luckin Coffee to Announce Second Quarter 2025 Financial Results on July 30, 2025
GlobeNewswire
·
July 23, 2025
BEIJING, July 23, 2025 (GLOBE NEWSWIRE) -- Luckin Coffee Inc. (“Luckin Coffee” or the “Company”) (OTC: LKNCY) will release its second quarter 2025 financial results before the U.S. market opens on Wednesday, July 30, 2025. The Company will hold a …
Novel Human Genetics Evidence Confirms Estimates of Genetic Prevalence, Underdiagnosis, and Potentially Greater Symptom Burden of Gain-of-Function CASR Variants Associated with ADH1
GlobeNewswire
·
July 23, 2025
- By examining over 100 unique variants associated with the CASR gene causative of ADH1, the average frequency of gain-of-function CASR variants was ~3.7 per 100,000, closely aligned to previously published estimates1 (3.9 per 100,000), which equates to …
Scientist Dr. Akiko Iwasaki Joins SPEAR Study Group to Investigate Monoclonal Antibodies for Long COVID and COVID-19 Post-Vaccination Syndrome
GlobeNewswire
·
July 23, 2025
WALTHAM, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), today announced the addition of Akiko Iwasaki, Ph.D., Professor of Immunobiology at Yale School of Medicine, to the SPEAR (Spike Protein Elimination and Recovery) Study Group. …
Neumora Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
GlobeNewswire
·
July 23, 2025
WATERTOWN, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven brain disease programs including three clinical-stage programs, today …
La Production de Silice Pyrogénée à L’échelle Pilote d’HPQ Approche la Viabilité Commerciale
GlobeNewswire
·
July 23, 2025
MONTRÉAL, 23 juill. 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique axée sur l’innovation dans le développement de matériaux avancés et de procédés critiques, a le …
HPQ’s Pilot-Scale Fumed Silica Production Nears Commercial Viability
GlobeNewswire
·
July 23, 2025
MONTREAL, July 23, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in advanced materials and critical process development, is pleased to update shareholders on …
WEBUY GLOBAL LTD. Partners with Victory Securities to Pioneer Stablecoin Adoption
GlobeNewswire
·
July 23, 2025
Singapore, July 23, 2025 (GLOBE NEWSWIRE) -- WEBUY GLOBAL LTD. (Nasdaq: WBUY) (“Webuy” or the “Company”), a fast-growing Southeast Asian e-commerce and travel tech company, is pleased to announce its intention to explore further collaboration on stablecoin …
First Atlantic Nickel Unveils Initial Phase 2 Drill Plan Map with Drilling Underway Following Phase 1 Discovery at RPM Zone Confirming First Large-Scale Awaruite in the Atlantic
GlobeNewswire
·
July 23, 2025
GRAND FALLS-WINDSOR, Newfoundland and Labrador, July 23, 2025 (GLOBE NEWSWIRE) -- First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) ("First Atlantic" or the "Company") is pleased to announce the release of its Initial Phase 2 Drill Plan Map …